(16617218), D. O. K., (16617221), S. P., (16617224), Y. S., (16617227), M. J. S., (16617230), L. B., (11099556), J. O. B., & (16617233), J. L. (2025). Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors.
Style de citation Chicago (17e éd.)(16617218), David Olayinka Kamson, Sushant Puri (16617221), Yingying Sang (16617224), Meihui Jessica Shi (16617227), Lindsay Blair (16617230), Jaishri O. Blakeley (11099556), et John Laterra (16617233). Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors. 2025.
Style de citation MLA (9e éd.)(16617218), David Olayinka Kamson, et al. Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors. 2025.